R. Boellaard, Standards for PET Image Acquisition and Quantitative Data Analysis, Journal of Nuclear Medicine, vol.50, issue.Suppl_1, 2009.
DOI : 10.2967/jnumed.108.057182

R. Boellaard, Methodological Aspects of Multicenter Studies with Quantitative PET, Methods Mol Biol
DOI : 10.1007/978-1-61779-062-1_18

R. Boellaard, Mutatis Mutandis: Harmonize the Standard!, Journal of Nuclear Medicine, vol.53, issue.1, pp.1-3, 2012.
DOI : 10.2967/jnumed.111.094763

E. Association-of-nuclear-medicine and . Earl-fdg-pet, http://earl.eanm.org/cms/website.php?id=/en/projects/fdg_pet_ct_accreditation.htm. 6. The Society of Nuclear Medicine and Molecular Imaging Clinical trials network (SNMMI-CTN), 2015.

N. Makris, M. Huisman, P. Kinahan, A. Lammertsma, and R. Boellaard, Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures, European Journal of Nuclear Medicine and Molecular Imaging, vol.53, issue.Suppl 1, pp.1507-1522, 2013.
DOI : 10.1007/s00259-013-2465-0

V. Panin, F. Kehren, C. Michel, and M. Casey, Fully 3-D PET reconstruction with system matrix derived from point source measurements, IEEE Transactions on Medical Imaging, vol.25, issue.7, pp.907-928, 2006.
DOI : 10.1109/TMI.2006.876171

E. Teoh, D. Mcgowan, R. Macpherson, K. Bradley, and F. Gleeson, Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System, Journal of Nuclear Medicine, vol.56, issue.9
DOI : 10.2967/jnumed.115.159301

D. Bellevre, B. Fournier, C. Switsers, O. Dugue, A. Levy et al., Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?, European Journal of Nuclear Medicine and Molecular Imaging, vol.40, issue.Suppl 2, pp.1103-1210, 2014.
DOI : 10.1007/s00259-014-2689-7

R. Boellaard, R. Delgado-bolton, W. Oyen, F. Giammarile, K. Tatsch et al., FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0, European Journal of Nuclear Medicine and Molecular Imaging, vol.28, issue.10, pp.328-54, 2015.
DOI : 10.1007/s00259-014-2961-x

C. Lasnon, C. Desmonts, E. Quak, R. Gervais, P. Do et al., Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients, European Journal of Nuclear Medicine and Molecular Imaging, vol.49, issue.Suppl 1, pp.985-9610, 2013.
DOI : 10.1007/s00259-013-2391-1

E. Quak, L. Roux, P. Hofman, M. Robin, P. Bourhis et al., Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients, European Journal of Nuclear Medicine and Molecular Imaging, vol.52, issue.Suppl 2, 2015.
DOI : 10.1007/s00259-015-3128-0
URL : https://hal.archives-ouvertes.fr/hal-01276023

J. Mertens, A. Dobbeleir, H. Ham, D. Asseler, Y. Goethals et al., Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases, European Journal of Nuclear Medicine and Molecular Imaging, vol.33, issue.9, pp.1441-1449, 2012.
DOI : 10.1007/s00259-012-2166-0

D. Visvikis, M. Hatt, and F. Tixier, Cheze Le Rest C. The age of reason for FDG PET image-derived indices

E. Naqa, I. Grigsby, P. Apte, A. Kidd, E. Donnelly et al., Exploring feature-based approaches in PET images for predicting cancer treatment outcomes Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters, Pattern Recognit. Acta Oncol, vol.4249, pp.1162-711012, 2009.

J. Yan, J. Chu-shern, H. Loi, L. Khor, A. Sinha et al., Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort, J Nucl Med. J Nucl Med, vol.5656, pp.1667-7338, 2015.

J. Calais, B. Dubray, L. Nkhali, S. Thureau, C. Lemarignier et al., High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer Image-derived biomarkers and multimodal imaging strategies for lung cancer management, Eur J Nucl Med Mol Imaging. Eur J Nucl Med Mol Imaging, vol.4242, pp.858-67634, 2015.

S. Takeuchi, B. Khiewvan, P. Fox, S. Swisher, E. Rohren et al., Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.362, issue.5, pp.906-1410, 2014.
DOI : 10.1007/s00259-013-2672-8

P. Vera, S. Mezzani-saillard, A. Edet-sanson, J. Menard, R. Modzelewski et al., FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2) Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors, Eur J Nucl Med Mol Imaging. Radiology, vol.41278, pp.1057-65214, 2014.

P. Lovinfosse, Z. Janvary, P. Coucke, S. Jodogne, C. Bernard et al., FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.102, issue.2, pp.259-275
DOI : 10.1007/s00259-016-3314-8

N. Aide, C. Desmonts, J. Beauregard, T. Beyer, K. Kinross et al., High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications, European Journal of Nuclear Medicine and Molecular Imaging, vol.176, issue.Suppl 2, pp.991-100110, 2010.
DOI : 10.1007/s00259-009-1352-1

M. Hatt, C. Le-rest, C. Turzo, A. Roux, C. Visvikis et al., A Fuzzy Locally Adaptive Bayesian Segmentation Approach for Volume Determination in PET, IEEE Transactions on Medical Imaging, vol.28, issue.6, pp.881-93, 2008.
DOI : 10.1109/TMI.2008.2012036
URL : https://hal.archives-ouvertes.fr/inserm-00372910

M. Hatt, C. Le-rest, C. Albarghach, N. Pradier, O. Visvikis et al., PET functional volume delineation: a robustness and repeatability study, European Journal of Nuclear Medicine and Molecular Imaging, vol.97, issue.12, pp.663-72, 2011.
DOI : 10.1007/s00259-010-1688-6
URL : https://hal.archives-ouvertes.fr/inserm-00574273

M. Hatt, C. Rest, C. Aboagye, E. Kenny, L. Rosso et al., Reproducibility of 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET Tumor Volume Measurements, Journal of Nuclear Medicine, vol.51, issue.9, pp.1368-76, 2010.
DOI : 10.2967/jnumed.110.078501
URL : https://hal.archives-ouvertes.fr/inserm-00537774

M. Hatt, C. Le-rest, C. Descourt, P. Dekker, A. et al., Accurate Automatic Delineation of Heterogeneous Functional Volumes in Positron Emission Tomography for Oncology Applications, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.1, 2010.
DOI : 10.1016/j.ijrobp.2009.08.018
URL : https://hal.archives-ouvertes.fr/inserm-00537776

A. Arens, E. Troost, B. Hoeben, W. Grootjans, J. Lee et al., Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies, Eur J Nucl Med Mol Imaging. Eur J Nucl Med Mol Imaging, vol.4138, pp.915-241636, 1007.

M. Hatt, F. Tixier, C. Le-rest, C. Pradier, O. Visvikis et al., Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.44, issue.Spec No 1, pp.1662-7110, 2013.
DOI : 10.1007/s00259-013-2486-8

F. Tixier, M. Hatt, L. Rest, C. , L. Pogam et al., Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET El Naqa I. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities, J Nucl Med. Phys Med Biol, vol.53606014, pp.693-7005471, 2012.

A. Webb, Introduction to Biomedical Imaging, Medical Physics, vol.30, issue.8, 2003.
DOI : 10.1118/1.1589017

M. Nyflot, F. Yang, D. Byrd, S. Bowen, G. Sandison et al., Quantitative radiomics: impact of stochastic effects on textural feature analysis implies the need for standards Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer, CT Studies: Impact of Reconstruction and Delineation. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, pp.145-52, 2015.

D. Groheux, M. Majdoub, F. Tixier, L. Rest, C. Martineau et al., Do clinical, histological or immunohistochemical primary tumour characteristics translate into different 18F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?, European Journal of Nuclear Medicine and Molecular Imaging, vol.43, issue.11, pp.1682-91, 2015.
DOI : 10.1007/s00259-015-3110-x
URL : https://hal.archives-ouvertes.fr/inserm-01171706

S. Ha, H. Choi, G. Cheon, K. Kang, J. Chung et al., Autoclustering of Non-small Cell Lung Carcinoma Subtypes on 18F-FDG PET Using Texture Analysis: A Preliminary Result, Nuclear Medicine and Molecular Imaging, vol.49, issue.7, pp.278-8610, 2014.
DOI : 10.1007/s13139-014-0283-3

C. C. Chung, M. Garcia-velloso, M. Lozano, T. Labiano, V. Diaz et al., Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive nonsmall cell lung cancers: an update for recent advances in therapeutics)F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer, J Oncol Pharm Pract. Role of Eur J Nucl Med Mol Imaging, vol.41, issue.18, pp.2058-6510, 1007.

K. Ko, H. Hsu, T. Huang, H. Gao, D. Shen et al., Value of 18F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.39, issue.10
DOI : 10.1007/s00259-014-2802-y